Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran
Genetic Testing and Molecular Biomarkers · 2025
DOI: 10.1089/gtmb.2025.0075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2025. Verfasst von Mohadeseh Sheykhi-Sabzehpoush und 5 weiteren Autor:innen. Beteiligte Einrichtung: Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: COVID-19, Interleukin-6. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Aim
Genetic predisposition is an important factor related to the enhancement of inflammation or immune responses in COVID-19 patients. This study aimed to explore the association between the IL-6 (rs1800795) polymorphism and COVID-19 severity in the southwest of Iran.
Methods
We evaluated these variants in 100 patients with moderate and 100 patients with severe COVID-19 using an (Amplification Refractory Mutation System Polymerase Chain Reaction) ARMS-PCR assay. In addition, we collected clinical characteristics of patients to assess their association with the severity of COVID-19. Statistically, the significance in the present evaluation was p < 0.05.
Results
Our findings showed a significant association with the SNP-174G/C of the IL-6 gene between the moderate and severe groups of COVID-19 patients under the dominant and codominant genetic models (p = 0.02 and 0.03, respectively). The frequency of the G allele was notably higher in the severe group compared to the moderate group (p = 0.02). Also, the rs1800795 genotypes, as well as the patients' age and gender (p = 0.13 and 0.31, respectively), were detected. Additionally, we confirmed a significant correlation between clinical data known as risk factors for COVID-19 severity.
Conclusion
Taken together, understanding the risk factors associated with the increased severity of COVID-19 may provide the opportunity for early and useful intervention in individuals at higher risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID-Profile: Mohadeseh Sheykhi-Sabzehpoush
Zitieren
APA
Sheykhi-Sabzehpoush, M., Khodadadi, A., Sharifat, M., Haddadzadeh Shoushtari, M., Raji, H., & Ghadiri, A. A. (2025). Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2025.0075
Vancouver
Sheykhi-Sabzehpoush M, Khodadadi A, Sharifat M, Haddadzadeh Shoushtari M, Raji H, Ghadiri AA. Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran. Genetic Testing and Molecular Biomarkers. 2025. doi:10.1089/gtmb.2025.0075
BibTeX
@article{SheykhiSabzehpoush2025,
author = {Sheykhi-Sabzehpoush, Mohadeseh and Khodadadi, Ali and Sharifat, Moosa and Haddadzadeh Shoushtari, Maryam and Raji, Hanieh and Ghadiri, Ata A},
title = {Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2025},
doi = {10.1089/gtmb.2025.0075}
}
EUVIMED